• 18
  • 9
  • 收藏

Pfizer in talks with India over expedited approval for COVID-19 vaccine

Reuters2021-05-03

NEW DELHI, May 3 (Reuters) - Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.

"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."

(Reporting by Krishna N. Das; Editing by Tom Hogue)

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论9

  • MCYR
    ·2021-05-03
    its a mess in India
    回复
    举报
  • Nicolas_Lim_
    ·2021-05-03
    like n comment pls
    回复
    举报
    收起
    • MZ39
      sure! hope india's situation will improve, if not the whole world affected = another stock crash?
      2021-05-06
      回复
      举报
  • AppleMango
    ·2021-05-03
    Is this the main reason why India is not able to get the vaccine?
    回复
    举报
  • Iinus
    ·2021-05-03
    Indian Govt dragging their feet 
    回复
    举报
    收起
    • mahi
      safety of population must be the top priority
      2021-05-03
      回复
      举报
    • mahi
      indeed
      2021-05-03
      回复
      举报
  • Milawow
    ·2021-05-03
    Pray for India
    回复
    举报
  • MKSoh
    ·2021-05-03
    Too bad cannot help. More people dying.
    回复
    举报
  • Milawow
    ·2021-05-03
    Pray for India
    回复
    举报
  • Kennyoscar
    ·2021-05-03
    Wa
    回复
    举报
  • kstle
    ·2021-05-03
    Pray for India [Comfort] 
    回复
    举报
 
 
 
 

热议股票

 
 
 
 
 

7x24